Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Pulido
Reduction of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan in the Randomized Controlled Trial Seraphin
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pulmonary Hypertension Due to Acute Respiratory Distress Syndrome
Brazilian Journal of Medical and Biological Research
Immunology
Cell Biology
Pharmacology
Biochemistry
Biophysics
Neuroscience
Medicine
Toxicology
Physiology
Pharmaceutics
Related publications
Correction to Figures In: Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Characterizing Patients Treated With Macitentan for Pulmonary Arterial Hypertension (PAH) in the U.S. Opsumit Users Registry (OPUS)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Anastrozole in Pulmonary Arterial Hypertension (AIPH): A Randomized, Double-Blind Placebo-Controlled Trial
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
P2 In-Flight Hypoxaemia in Patients With Pulmonary Arterial Hypertension (PAH)
Thorax
Pulmonary
Respiratory Medicine
Hospitalization Costs Related to Pulmonary Hypertension (Ph) Among Medicare Advantage or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Therapeutic Challenges and Advances in the Management of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
Therapeutics and Clinical Risk Management
Neprilysin Inhibition for Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial
British Journal of Pharmacology
Pharmacology
Development of a New Patient-Reported Outcome (PRO) Instrument for Pulmonary Arterial Hypertension (PAH): The Pulmonary Arterial Hypertension–symptoms and Impact (PAH-SYMPACT) Questionnaire
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
